MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to biocorrx inc
-$3,440,146
(34.00%↑ Y/Y)
Non-controlling interest
-$68,617
(-164.75%↓ Y/Y)
Net loss
-$3,508,763
Grant income
$2,435,848
(65.34%↑ Y/Y)
Other miscellaneous
income
$223,037
(72.52%↑ Y/Y)
Loss before
provision for income taxes
-$3,508,763
(32.68%↑ Y/Y)
Total other
(expenses) income, net
$1,322,879
(1576.48%↑ Y/Y)
Supply and
distribution sales
$795,454
(19565.12%↑ Y/Y)
Sales/access fees
$1,790
(-18.82%↓ Y/Y)
Interest expense -
related parties
$637,705
(-15.06%↓ Y/Y)
Change in fair value of
royalty liability
-$279,511
Interest expense, net
$223,850
(-71.18%↓ Y/Y)
Loss on settlement of
debt
-$187,514
(-13.92%↓ Y/Y)
Change in fair value of
upfront purchase price...
-$7,426
Loss from operations
-$4,831,642
(5.68%↑ Y/Y)
Revenues, net
$797,244
(10301.10%↑ Y/Y)
Total operating
expenses
$5,628,886
(9.72%↑ Y/Y)
Selling, general and
administrative
$3,794,126
(5.03%↑ Y/Y)
Research and development
$1,768,955
(19.29%↑ Y/Y)
Depreciation and
amortization
$44,003
(32.76%↑ Y/Y)
Cost of implants and
other costs
$21,802
(1207.86%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BioCorRx Inc. (BICX)
BioCorRx Inc. (BICX)